Ofloxacin Featured News
143 items
-
25
AprFuxiang Pharmaceutical Will Achieve Operating Income of 1.493 Billion Yuan in 2020, and the Main Business Has Not Changed
During the reporting period, the company’s main business remained unchanged, focusing on the R&D, production and sales of high-end antibiotic APIs and their intermediates. -
25
AprHeilongjiang Huarui Biomedicine's 10 Billion Project Is Progressing Smoothly And Is Scheduled to Be Put into Operation in October 2021
There are currently more than 1,000 construction personnel on the entire site. The project is planned for 2021. Started production in October. -
22
AprThe production base of Chifeng Desano Pharmaceutical Co., Ltd. held a grand opening ceremony
Saibei's spring willow green, Hongshan adds a new blueprint. On April 18, the commemoration ceremony of the key projects in Hongshan District of Chifeng City was held at the production base of Chifeng Disano Pharmaceutical Co., Ltd. -
21
AprPropharm will achieve sales revenue of 5.9 billion yuan in APIs in 2020, and CDMO will achieve revenue of 1.055 billion yuan
Prologue Pharmaceutical Co., Ltd. announced its 2020 performance on March 20: 2020 is an extraordinary year. -
18
AprPharmaceutical companies exposed the monopoly of ornidazole raw materials, and the Market Supervision Administration intervened in the investigation
The raw material drug companies exposed to the public the inside story of the monopoly of the domestic ornidazole raw material drug market. -
16
AprCSPC 'Study on Key Technologies for the Industrialization of Carbapenem Drugs' won the first prize of Provincial Science and Technology Progress Award
On April 13, the 2020 Hebei Science and Technology Awards Conference was held in Shijiazhuang, and 262 projects (persons/organizations) won the 2020 Hebei Science and Technology Awards. -
15
AprTosun Pharma selects ABEC large-scale fermentation tank to increase biopharmaceutical production capacity
ABEC, a global biopharmaceutical manufacturing integrated solution and service provider, announced on April 13 that it will design -
15
AprHeilongjiang Huarui Biotechnology Co., Ltd. invested 2.35 billion yuan in the second phase of biomedicine project
"Heilongjiang Huarui biotechnology Limited biomedical project (Phase II)" Environmental Impact Assessment for the first time publicity -
14
AprRuicheng Technology Nucleotide Series Pharmaceutical Intermediate Project started construction in Xinxiang County on April 8th
Xinxiang County held the second quarter of 2021 key project concentrated start activity-Ruicheng Technology Nucleotide Series Pharmaceutical Intermediate Project Commencement Ceremony -
13
AprXinxiang Haibin Pharmaceutical invested 226 million yuan to rebuild the Penem series of APIs, adding imipenem and other products
It belongs to the permitted category and has been filed with the Xinxiang High-tech Industrial Cluster Management Committee (project code: 2020- 410771-27-03-095132). -
13
AprShandong Huihai Pharmaceutical Chemical Co., Ltd. started the construction of the Penan high-end pharmaceutical intermediate project
Approval of "Slimming" Service "Afterburning" Dongying Hekou fully promoted the implementation of key projects on March 26, "I didn't expect that we had to go through several departments to go through the procedures and toss back -
13
AprShandong Huihai Pharmaceutical and Chemical Co., Ltd. invested 360 million yuan to build 4-AA Penem intermediates and other projects
Existing project and environmental protection: Existing project Including 1000t/aAABI (5-acetoacetamidobenzimidazolone) project, 5000t/a triethyl synthesis unit phase II project, 1000t/aDCC project, sewage treatment transformation project (2013). -
12
AprOverview of Import and Export of Pharmaceutical Commodities in China's International Trade of APIs in 2020
The import and export of pharmaceutical products in 2020 will continue to maintain a good growth trend. The total value of imported pharmaceutical products was 40.478 billion U.S. dollars. -
12
AprChanges in the overall scale of import and export of APIs in China's international trade of APIs in 2020
Changes in the overall scale of import and export of APIs in the overview of China's API international trade in 2020 Tracking the import value for more than ten consecutive years shows that the import of API commodities. -
12
AprOverview of China's International Trade of APIs: Structure of Import and Export APIs in 2020
Imported raw materials are evenly dispersed in various treatment and application fields. Imported biochemical raw materials have the largest proportion, including recombinant and ordinary insulin raw materials. -
12
AprDistribution structure of raw material medicine exporting countries-an overview of China's raw material medicine international trade in 2020
The exporting countries of raw materials are distributed in more than 180 countries and regions, such as India, the United States, the European Union, Japan, Brazil, Vietnam, Mexico and so on -
12
AprAn overview of China's international trade of APIs in 2020-the bulk of export APIs in 2020
Health.com has tracked and analyzed more than 800 single varieties of API intermediates. In 2020, the export value will be over 100 million U.S. dollars, a total of 37 types. Heparin sodium-based bulk medicines topped the list with a total of 1.4 billion. -
12
AprAn Overview of China's International Trade of APIs in 2020-Antibiotic APIs Are Unabated
Antibiotic APIs are China's key export areas. According to statistics in 2020, the total export volume of antibiotics is 88,000 tons, with a total export value of 3.833 billion U.S. dollars. -
12
AprAn Overview of China's International Trade of APIs in 2020-Vitamins Increase in Price
In 2020 , the total export volume of vitamins is 358,100 tons, and the total export volume is 3.595 billion US dollars. The export volume decreased by 22.22% year-on-year, and the value increased by 21.4% year-on-year. -
12
AprOverview of China's international trade of APIs in 2020-steroid hormones out of the trough
Estrogen, progestin and androgen steroid hormones and glucocorticoids composition is another major advantage of the characteristics of the port drug species.
Breaking News
-
Styrene Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
Tianjin Haijing Polyamide 6 Slice Price News (2026-09-09)
Sep 9 -
Methanol Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
Benzene Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
[Styrene]: September 9, 2026 Asian Market Styrene Price Dynamics
Sep 9 -
[PPC]: Zhejiang Huafeng Environmental PPC Price News (2026-09-09)
Sep 9
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)